For US Residents only

Actor portrayal.

Let In The Lyte logo

SIGNIFICANT RELIEF FROM
DEPRESSION SYMPTOMS IN:

Major Depressive Disorder (MDD)
as an add‑on to an antidepressant*Arrow iconBipolar I & Bipolar II Depression†Arrow icon

*CAPLYTA is FDA-approved to treat adults with major depressive disorder used along with an antidepressant.

†CAPLYTA is proven to deliver significant relief from symptoms of bipolar I and II depression. CAPLYTA can be taken alone or with lithium or valproate.

Over 5 years, more than 1 million prescriptions

‡Based on total prescriptions dispensed across approved indications since CAPLYTA was FDA‑approved in 2019.
MDD indication was approved in November 2025.

Once you and your doctor have decided that CAPLYTA is right for you

CAPLYTA with me

Streamlined support to help you start and stay on CAPLYTA with confidence

FIND SAVINGS AND COST SUPPORT FOR YOUR CAPLYTA PRESCRIPTION

For patients using commercial insurance

CAPLYTA withMe
Savings Program

Pay as little as $0 for 30-, 60-, or 90-day prescriptions
AND
As little as $0 for generic antidepressant
savings card

Maximum program benefit per calendar year shall apply. Offer subject to change or end without notice. Restrictions, including monthly maximums, may apply. See program requirement at CAPLYTAwithMeSavings.com

Download Savings CardArrow icon

The support and resources provided by CAPLYTA withMe are not intended to provide medical advice, replace a treatment plan you receive from your doctor or nurse, or serve as a reason for you to start or stay on treatment.

Doctor discussion guide icon

Prepare for your next visit

Answer these questions to HELP guide your Conversation about CAPLYTA

Build Your Doctor Discussion GuideArrow icon
Loading Global Footer...